Sickle cell gene therapies offer new hope, but access remains a major challenge

Source: cnbc October 16, 2026 · 07:43
Sickle cell gene therapies offer new hope, but access remains a major challenge
Photo by Satheesh Sankaran · Pexels
From the publisher
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
About the source

CNBC

The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…

Wikipedia
Wikidata Q1023912
Wikidata ↗

The original article opens on the publisher's website.

More from General

View topic →